SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-061402
Filing Date
2020-05-14
Accepted
2020-05-14 13:10:22
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014669d1_10q.htm 10-Q 378416
2 EXHIBIT 31.1 tm2014669d1_ex31-1.htm EX-31.1 10155
3 EXHIBIT 31.2 tm2014669d1_ex31-2.htm EX-31.2 10112
4 EXHIBIT 32.1 tm2014669d1_ex32-1.htm EX-32.1 4037
5 EXHIBIT 32.2 tm2014669d1_ex32-2.htm EX-32.2 4184
  Complete submission text file 0001104659-20-061402.txt   3096576

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyen-20200331.xml EX-101.INS 726430
7 XBRL TAXONOMY EXTENSION SCHEMA eyen-20200331.xsd EX-101.SCH 34706
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyen-20200331_cal.xml EX-101.CAL 32456
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyen-20200331_def.xml EX-101.DEF 84062
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20200331_lab.xml EX-101.LAB 244128
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20200331_pre.xml EX-101.PRE 203162
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 20876659
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences